Fortis Inc. closed 2.6% below its 52-week high of C$64.39, which the company reached on February 14th.

In a report released yesterday, Maurice Choy from RBC Capital maintained a Hold rating on Fortis (FTS – Research Report), with a price target ...

Wells Fargo analyst Neil Kalton maintained a Hold rating on Fortis (FTS – Research Report) on February 14 and set a price target of C$66.00.

Fortis Inc. closed 2.9% short of its 52-week high of C$64.39, which the company achieved on February 14th.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

that it licensed last year from Fortis Therapeutics. At this year's ASCO, positive data was reported from an investigator-led phase 1b study that looked at the combination of FG-3246 with Pfizer ...

Earnings were up at Fortis in the fourth quarter of the year. Profit rose to $396-million, up from $381-million the same time last year. The St. John’s-based electric and gas utility says the profit ...

Rights Aug 18, 2009 Aug 20, 2009 Dec 24, 2008 Rights ratio: 2 share for every 5 held at a price of Rs 110.0 Rights-Aug 20, 2009 Aug 10, 2009 Rights ratio: 2 share for every 5 held at a price of Rs 110 ...

After hours: February 20 at 6:58:27 PM EST Loading Chart for NKTR ...

After hours: February 20 at 6:16:04 PM EST Loading Chart for PTIX ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Fortis Malar Hospitals Ltd., incorporated in the year 1989, is a Small Cap company (having a market cap of Rs 110.39 Crore) operating in Hospitals & Allied Services sector. Fortis Malar Hospitals Ltd.